Analysis of the efficacy of SGLT2 inhibitors using semi-mechanistic model
Author:
Publisher
Frontiers Media SA
Subject
Pharmacology (medical),Pharmacology
Reference33 articles.
1. The impact of mathematical modeling on the understanding of diabetes and related complications;Ajmera;CPT Pharmacometrics Syst. Pharmacol,2013
2. A new look at the statistical model identification;Akaike;IEEE Trans. Automat. Control,1974
3. Achievement of goals in U.S. diabetes care, 1999-2010;Ali;N. Engl. J. Med,2013
4. Simultaneous oral therapeutic and intravenous 14C-microdoses to determine the absolute oral bioavailability of saxagliptin and dapagliflozin;Boulton;Br. J. Clin. Pharmacol,2013
5. Pharmacokinetics of empagliflozin, a sodium glucose cotransporter-2 (SGLT-2) inhibitor, coadministered with sitagliptin in healthy volunteers;Brand;Adv. Ther,2012
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Impact of SGLT2 inhibitors on patient outcomes: a network meta-analysis;Cardiovascular Diabetology;2023-10-27
2. Mechanistic evaluation of the inhibitory effect of four SGLT-2 inhibitors on SGLT 1 and SGLT 2 using physiologically based pharmacokinetic (PBPK) modeling approaches;Frontiers in Pharmacology;2023-06-01
3. Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis;Frontiers in Pharmacology;2022-08-15
4. A systems-biology approach to molecular machines: Exploration of alternative transporter mechanisms;PLOS Computational Biology;2020-07-02
5. A Comprehensive Review on Preclinical Diabetic Models;Current Diabetes Reviews;2020-01-21
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3